INSILENS, A Noetera Company

Biotech Intelligence Platform

Turn Global Biotech Signals, Into Strategic Intelligence

Explore with us

Biotech Signals. Structured for Decisions.

INSILENS converts global biotech activity into decision-grade intelligence for investors, executives, and business development teams.

Deals and Financing
Therapeutic Indication
Technology Modalities
View all

Weekly Market Insight

CellCentric – $220M Financing for Inobrodib
Long-Acting Anti-Influenza Monoclonal Antibody Platform Targets Immunocompromised Patients
Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
GSK – $1B SiranBio Oligo Deal